Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP635932.RABNKVgXjQ-rJ6EgQmnvex9fSEwedmRt6vwDfGOWlGeDE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP635932.RABNKVgXjQ-rJ6EgQmnvex9fSEwedmRt6vwDfGOWlGeDE130_assertion type Assertion NP635932.RABNKVgXjQ-rJ6EgQmnvex9fSEwedmRt6vwDfGOWlGeDE130_head.
- NP635932.RABNKVgXjQ-rJ6EgQmnvex9fSEwedmRt6vwDfGOWlGeDE130_assertion wasGeneratedBy ECO_0000203 NP635932.RABNKVgXjQ-rJ6EgQmnvex9fSEwedmRt6vwDfGOWlGeDE130_provenance.
- NP635932.RABNKVgXjQ-rJ6EgQmnvex9fSEwedmRt6vwDfGOWlGeDE130_assertion wasDerivedFrom befree-2016 NP635932.RABNKVgXjQ-rJ6EgQmnvex9fSEwedmRt6vwDfGOWlGeDE130_provenance.
- NP635932.RABNKVgXjQ-rJ6EgQmnvex9fSEwedmRt6vwDfGOWlGeDE130_assertion SIO_000772 17943075 NP635932.RABNKVgXjQ-rJ6EgQmnvex9fSEwedmRt6vwDfGOWlGeDE130_provenance.
- NP635932.RABNKVgXjQ-rJ6EgQmnvex9fSEwedmRt6vwDfGOWlGeDE130_assertion evidence source_evidence_literature NP635932.RABNKVgXjQ-rJ6EgQmnvex9fSEwedmRt6vwDfGOWlGeDE130_provenance.
- NP635932.RABNKVgXjQ-rJ6EgQmnvex9fSEwedmRt6vwDfGOWlGeDE130_assertion description "[Notably, the same dosage of Andro did not further reduce neointimal formation in p50(-/-) mice, which implicates the specificity of Andro on p50 for treating experimental arterial restenosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635932.RABNKVgXjQ-rJ6EgQmnvex9fSEwedmRt6vwDfGOWlGeDE130_provenance.